News & Updates: HRT
The deadline to file claims has been extended September 19, 2016.
Pharma firm pays $13M settlement in hormone-replacement lawsuit
CTV News Report On HRT
La Presse : Un traitement hormonal aurait-il causé des cancers du sein?La Presse : Un traitement hormonal aurait-il causé des cancers du sein?
Cancer linked to menopause drug in new reportToronto Star: Cancer linked to menopause drug in new report
Notice of Certification: Hormone Therapy Class Action
The Supreme Court of British Columbia has ordered publication of Notice of Certification in the Hormone Therapy Class Action. Women in Canada who were diagnosed with breast cancer after taking Premarin in combination with progestin or Premplus may be able to join the class action. If you do not live in British Columbia you must opt-in before Monday, August 25, 2014 to participate. If you have any questions, please contact Klein Lawyers.
May 29, 2013
On May 29, 2013, we were successful in the BC Court of Appeal.
The Defendants were trying to limit the questions we could ask their former employees. But Justice Gropper ruled that our questions were relevant and material to when Wyeth knew or should have known about the link between hormone replacement therapy and the development of breast cancer. Madame Justice Prowse of the B.C. Court of Appeal agreed; she denied the Defendants attempt to appeal Justice Gropper’s decision. To read Madam Justice Prowse’s decision please click on the following link to the Court website: www.courts.gov.bc.ca/jdb-txt/CA/13/02/2013BCCA0256.htm
April 7, 2012
CBC Radio: Medical GhostwritingCBC Radio: Medical Ghostwriting (266 KB)
Class action lawsuit launched from Sechelt
Class-action suit OK’d: Breast cancer patients can sue drugmaker
Judge certifies class-action lawsuit against hormone therapy drugmakers
Class action suit linking drugs, cancer approved
Class Action Lawsuit against Wyeth to be Joined by Women in Canada
B.C. court certifies breast cancer class action
HRT class action case on breast cancer OK’d
Class-action breast cancer lawsuit approved
Court certifies breast cancer class-action lawsuit
Woman sues after menopause drug gives her breast cancer
Court Certifies Class Action for Canadian Women Harmed by HRT
Healthzone.ca: Ghostwriting is bad medicine
Media coverage related to Madam Justice Gropper’s decision
June 27, 2008
On June 27, 2008 Madam Justice Gropper issued Reasons for Judgement holding that the American corporate defendants in this lawsuit, all members of the Wyeth pharmaceuticals conglomerate, fall within the jurisdiction of B.C.’s courts and may be held responsible to Canadian consumers. (See February 2007 entry below for further discussion of this issue.) The American defendants have 30 days to decide whether to appeal the decision of Madam Justice Gropper. If they do not, the next significant step in this lawsuit will be the “certification hearing” during which the Plaintiff will request a court order designating this action as a class action. It will be several months before the certification hearing can take place. See the Reasons of Madam Justice Gropper (102 KB) issued June 27, 2008.
Before a lawsuit can be considered a class action, the Plaintiff has to apply to have it “certified” by the court. The certification hearing in this case will not take place until the case management judge, Madam Justice Gropper, has heard a “jurisdiction application” filed by all of the American Defendants. The American Wyeth companies have filed documents with the Supreme Court of British Columbia requesting a stay of this action against them on the grounds that the court has no jurisdiction over them. The date for the hearing of the jurisdiction application is not yet known.